Identification of Fusion Transcripts in Leukеmic Cells by Whole-Transcriptome Sequencing


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Genetic aberrations in leukemia often lead to the formation of expressed chimeric genes, which should be assessed for proper diagnosis and therapy. Modern methods of molecular diagnostic mainly allow to identify already known fusion genes. RNAseq is an efficient tool for identification of rare and novel chimeric transcripts. Here we present the results of the whole transcriptome analysis of bone marrow samples from five patients with acute myeloblastic leukemia and one, with myelodysplastic syndrome. The wholetranscriptome analysis was performed using Illumina/Solexa approach. We found rare or unknown chimeric transcripts including ETV6-MDS1, MN1-ETV6, OAZ1-PTMA, and MLLT10-GRIA4. Each of these transcripts was confirmed by RT-PCR and Sanger sequencing.

Sobre autores

A. Ikonnikova

Engelhardt Institute of Molecular Biology

Email: nased@biochip.ru
Rússia, Moscow, 119991

Yu. Ammour

Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology

Email: nased@biochip.ru
Rússia, Moscow, 119117

A. Snezhkina

Engelhardt Institute of Molecular Biology

Email: nased@biochip.ru
Rússia, Moscow, 119991

G. Krasnov

Engelhardt Institute of Molecular Biology

Email: nased@biochip.ru
Rússia, Moscow, 119991

A. Kudryavtseva

Engelhardt Institute of Molecular Biology

Email: nased@biochip.ru
Rússia, Moscow, 119991

T. Nasedkina

Engelhardt Institute of Molecular Biology; Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology

Autor responsável pela correspondência
Email: nased@biochip.ru
Rússia, Moscow, 119991; Moscow, 119117

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Inc., 2018